San Francisco, California
London, United Kingdom
Please join us for a multifaceted symposium focusing on the latest developments in drug discovery for Autism Spectrum Disorder. We will have multiple speakers elucidating the topic form a variety of angles, ranging from basic research to industry perspectives. This event is supported by UCLA BRI and department of Neurology.
Dr. Daniel Geschwind MD PhD (UCLA Human Genetics, Neurology and Psychiatry)
Dr. James McCracken MD (UCLA Psychiatry and Biobehavioral Sciences)
Dr. Thomas Otis PhD (UCLA Neurobiology/Roche Pharmaceuticals)
Dr. Daniel Campbell PhD (USC Psychiatry)
9:00 Opening remarks
9:15 Clinical testing of novel drugs for autism - James McCracken MD
9:45 Drug development for neurodevelopmental disorders - Thomas Otis PhD
10:15 Non-Coding RNAs in Autism: New Opportunities for Treatment Targets - Daniel Campbell PhD
10:45 Coffee break
11:00 Keynote lecture: Exploring mechanisms and therapies using In vitro and in vivo models - Daniel Geschwind MD PhD
12:00 Closing Remarks
12:15 Lunch and roundtable discussion (RSVP required)
Please follow the link below to RSVP for an informal roundtable discussion with the speakers (limited capacity). Lunch will be provided.
When & Where
Biotech Connection LA
Los Angeles is not only home to renowned universities and research institutes, but also harbors a vibrant biotech and life sciences industry. Biotech Connection Los Angeles (BCLA) is an organization run by students, postdocs and young professionals from all over Los Angeles. Our mission is to facilitate the connection between academics across disciplines with each other and the biotech industry to move innovation forward and expand their impact on healthcare.